Auna (AUNA) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 May, 2026Executive summary
Revenue grew 13% year-over-year to S/ 1,178 million in Q1 2026, with all segments contributing to growth across Mexico, Peru, and Colombia.
Adjusted EBITDA declined 2% YoY to S/ 217 million, with margin down 2.9 percentage points to 18.4%, impacted by extraordinary items, payor adjustments, and higher payroll expenses.
Free cash flow expanded 2.6x YoY to S/ 152 million, reflecting strong cash management and working capital discipline.
Leverage ratio stable at 3.7x, mainly due to non-cash FX effects.
Strategic focus on high-complexity services, risk-sharing contracts, and expanding plan memberships.
Financial highlights
Consolidated revenue reached S/ 1,178 million, up 13% YoY and 10% in constant currency.
Adjusted EBITDA margin contracted by 2.9 percentage points to 18.4%; operating profit rose 11% to PEN 155 million.
Free cash flow reached S/ 152 million, up from S/ 42 million YoY, driven by 45% higher pre-tax operating cash flow.
End-of-period cash rose 22% versus December 2025.
Adjusted EPS was S/ 0.18, down from S/ 0.70 in Q1 2025.
Outlook and guidance
Annual revenue and EBITDA guidance reaffirmed, expecting stronger growth in the second half of 2026.
Margin improvement anticipated in Mexico and Colombia as scale and operating leverage increase.
Initiatives underway to mitigate revenue adjustment impacts in Peru and optimize billing cycles.
Mexico anticipated to continue recovery, leveraging higher volumes and cost efficiencies.
Colombia to focus on balanced payor mix and reliable cash flows.
Latest events from Auna
- FY25 saw strong cash flow, Peru and Colombia growth, and a 12% FXN growth target for 2026.AUNA
Q4 202511 Mar 2026 - Adjusted EBITDA up 31% and revenue up 18% year-over-year, with leverage ratio at 4.13x.AUNA
Q2 202423 Jan 2026 - Adjusted EBITDA up 23% YoY, leverage ratio at 3.7x, and OncoMexico pilot advancing.AUNA
Q3 202413 Jan 2026 - Healthcare group targets $1B NYSE offering to expand Latin American operations.AUNA
Registration Filing16 Dec 2025 - Healthcare group seeks up to $1B in NYSE-listed shares to fund growth in Latin America.AUNA
Registration Filing16 Dec 2025 - FY24 Adjusted EBITDA up 20.1% FXN, margin and net income improved, leverage at 3.6x.AUNA
Q4 20243 Dec 2025 - Peru's growth offset Mexico and Colombia's declines, sustaining profitability and stable leverage.AUNA
Q1 202526 Nov 2025 - Adjusted EBITDA up 5% FXN YoY; net income surged; leverage steady amid FX headwinds.AUNA
Q2 202523 Nov 2025 - Peru and Colombia grew, Mexico declined; leverage stable, refinancing done, Mexico recovery in 2026.AUNA
Q3 202521 Nov 2025